Revenue beats 20% guide at 23%, margins miss at 14% vs 15-16% target
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Beat revenue guide (20% → 23%), missed margin guidance (15–16% → 14%); communicated facility delays transparently.
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Revenue growth of 23% outpaced prior 20% guidance, but EBITDA margins compressed to 14% versus 15–16% target due to forex, freight, and input-cost headwinds. Pacific Global acquisition and greenfield Vizianagaram facility set up transformational FY27–FY28, but execution risk remains—facility trials already delayed 45 days.
₹143.4 Cr
Revenue · +23% YoY₹12.6 Cr
Reported PAT · +null% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
H1 FY27 revenue up 23% YoY to ₹145 Cr
METDelivered Q2 FY27 ₹143.4 Cr; H1 aggregate consistent with 23% YoY growth claim
EBITDA margins 14% in H1, up 190 bps vs H2 FY26
OVERSTATEDNPM 8.7% reported; EBITDA margin at 14% falls short of prior 15-16% guidance
PAT ₹12.6 Cr, grew 19% vs H2 prior year
METDelivered PAT ₹12.6 Cr exactly matches; growth rate verified
Plant utilization 95% vs 86% prior year
METStrong efficiency gains; capacity absorption accelerating
Institutional revenue 37.5% vs 34% prior year
METChannel mix improving; recurring large orders from food/snack conglomerates documented
Earnings quality
What changed since the last call
Margin guidance tacitly abandoned
DowngradePrior guidance 15–16% EBITDA margins; H1 FY27 delivered 14%, with no reconfirmation of recovery target. Management cited forex/freight/input costs but did not quantify revised margin expectations.
Global expansion accelerated
UpgradePacific Global FZCO acquisition (60k MT Africa, world's largest raw cashew producer) approved and valued at share swap; moves Pajson from India-centric to global player in one transaction.
Institutional channel momentum
UpgradeInstitutional customers grew to 37.5% of revenue (from 34% prior year); large recurring orders from food/snack conglomerates now 178 distributors across 20+ states.
Vizianagaram timeline extended
DowngradeFacility trials delayed by 45 days (cyclone disruptions); now Feb or Q4 FY27 instead of Nov–Dec; FY27 revenue contribution negligible per management.
The Q&A
Analysts pressed hard on valuation (Purva Shah: Pajson market cap ~₹750 Cr vs 60k MT African facility), margin defensibility (Aryan Bhatia: margins fell from 18% to 12–13%), and execution timelines (Abhishek Malhotra: facility delay justification). Management held ground but remained cautious, refrained from specific forward EBITDA numbers, and emphasized long-term structural opportunity over near-term numbers.
Expansion and African strategy — Akash Agarwal, Individual Investor
AnsweredFocus is on building solid business foundation and scalable operations, not short-term profitability. Confident geopolitical headwinds are temporary; first-half performance will be taken into second half.
Greenfield facility progress — Abhishek Malhotra, Individual Investor
AnsweredDelayed by 45 days (cyclones Arnab, Musaru); now targeting trials by February or Q4 FY27. This year very little revenue from new plant coming into FY27 numbers. Expected to support margins and volumes thereafter.
Acquisition valuation and structure — Mayur Parekh, Vy Capital
AnsweredShare swap valued at close to NAV of Pacific Global; no cash consideration to promoters. Combined earnings expected much higher; investment case strong on EPS accretion even after dilution.
Capacity utilization post-acquisition — Purva Shah, Grobiz Fund
PartialPacific Global is a greenfield pre-revenue entity in Cote d'Ivoire; not comparable to Pajson's profitable India operations. Profitability in African facility higher; company at production hub level, not yet reflecting global market margins.
Margin outlook and sourcing advantage — Aryan Bhatia, InVed Research
AnsweredMultiple factors: FY26 was better due to festivities; H1 FY27 faced geopolitical pressure, forex movement, freight costs up. African margins definitely 5–7% higher than India due to origin processing. Long-term margins will improve.
Consolidation timeline and working capital — Deepak Poddar, Sapphire Capital
AnsweredConsolidation expected in 2–3 months (Jan–Feb FY27). Working capital will increase as farm-to-fork model requires inventory in Africa; offset by better inventory management with direct farm relationships.
FY28 EBITDA outlook and margin assumptions — Anish Garg, Finstar
DodgedCannot comment on numeric EBITDA numbers. Growth numbers speak for themselves—18k MT current India + 35k MT Vizianagaram + 60k MT Africa = 113k MT combined.
Royal Mewa brand buildout — Rakshit Kavada, Vy Capital
AnsweredRoyal Mewa is a long-term play; currently 4.6% of revenue vs 1.36% prior year. Target is 15% in next 3–5 years, growing carefully via offline, online, and corporate gifting without sacrificing bottom-line disciplinarily.
Debt and financing for capacity expansion — Kumar Vivek, Individual Investor
AnsweredNo long-term debt in acquisitions; promoting farm-to-fork model will improve working capital. Expanding facilities will need working capital lines from institutions; expansion will be through internal accruals.
African processing facility sourcing and margins — Anish Garg, Finstar
AnsweredGreenfield project; interest was shown at board level by existing shareholders. Built by our group with supplier relationships and operational arrangements. Now consolidated as Pacific Global; sourcing and strengthening procurement arm for global markets.
Guidance
FY27 ~20% growth from existing ops (prior guidance); H1 achieved 23% YoY
HighExceeds stated guidance; institutional growth and capacity absorption driving momentum. H2 expected similar trajectory per management tone.
FY27–FY28: Combined 113k MT capacity (India + Africa) operational
MediumVizianagaram trials Feb/Q4 FY27; African operations by next FY. Execution tied to facility commissioning and integration timelines.
Global cashew market share target 5–8% in 5–7 years
MediumLong-term aspiration; global market ~30–35% India standalone, rest Africa/global. Requires flawless execution and market share capture.
15–16% EBITDA margin recovery (prior FY26 guidance); H1 FY27 at 14%
LowMissed in H1; management cited forex, freight, input costs as temporary. Did not reconfirm recovery target; long-term margin expansion promised post-African integration.
African facility margins 5–7% higher than India operations
MediumBased on origin processing advantage and global market access; unproven in consolidated financials.
Vizianagaram: 35k MT facility capex via IPO proceeds
HighIPO deployed as planned; facility under construction; delays communicated transparently (45 days due to cyclones).
Pacific Global acquisition: share-swap deal, no debt
HighBoard-approved; valuation at NAV; no ongoing capex required; facility already 60k MT operational capacity.
Risks the call surfaced
Geopolitical forex headwinds
HighForex movement and geopolitical disturbance described as unprecedented pressure on margins in H1 FY27. INR weakness directly hits imported raw cashew pricing and export realization.
Input-cost inflation
HighRaw cashew nut prices remain elevated; coupled with freight cost increases, margin recovery is dependent on pricing power and operational efficiencies, not volume.
Execution risk on new facilities
MediumVizianagaram greenfield already delayed 45 days (cyclones Arnab, Musaru); trials now Feb or Q4 FY27. Further delays risk FY28 ramp and full 113k MT utilization targets.
Pacific Global integration
MediumShare-swap acquisition of 100% Pacific Global (Cote d'Ivoire, 60k MT); no majority promoter premium demanded, but risk of operational complexity, governance at scale, and consolidated working capital growth.
Concentrated supply and customer risk
MediumSourcing heavily reliant on Africa (Ivory Coast is world's largest raw cashew producer); institutional channel growing (37.5%) but still dependent on large food/snack conglomerates for recurring orders.
Management
Score 7/10. Clear on challenges (geopolitical, freight, input costs); transparent on facility delays and reasons. Cautious on forward EBITDA numbers (declined to comment on FY28 specifics). Candid on margin compression drivers and strategic pivot to global footprint. Met revenue growth guidance beat (20% → 23%); missed margin recovery target (15–16% → 14%). Delivered Pacific Global acquisition and greenfield facility despite setbacks; communicated delays transparently. Institutional channel growth and Royal Mewa momentum deliver.
1 · Feb 2027 / Q4 FY27
Vizianagaram greenfield facility trials and commercial production ramp
2 · FY28
Pacific Global (60k MT Cote d'Ivoire) operational; African margin uplift materializes
3 · FY28
Consolidation of Pacific Global into Pajson; combined 113k MT capacity live
Pacific Global acquisition and greenfield Vizianagaram facility set up transformational FY27–FY28, but execution risk remains—facility trials already delayed 45 days.
Informational and educational content only. Not investment advice.